Cargando…

Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials

BACKGROUND: The efficacy and safety of preoperative chemoradiation therapy (CRT) for advanced esophago-gastric adenocarcinoma are still in question, and the prognosis of these patients is poor. METHODS: We systematically searched electronic databases from January 1990 to July 2014. The primary outco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Tao, Bu, Zhao-De, Li, Zi-Yu, Zhang, Lian-Hai, Wu, Xiao-Jiang, Wu, Ai-Wen, Shan, Fei, Ji, Xin, Dong, Qiu-Shi, Ji, Jia-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415228/ https://www.ncbi.nlm.nih.gov/pubmed/25928286 http://dx.doi.org/10.1186/s12885-015-1341-7

Ejemplares similares

Neoadjuvant Chemoradiation Treatment for Resectable Esophago-Gastric Cancer: A Systematic Review and Meta-Analysis
por: Meng, Xiangyu, et al.
Publicado: (2019)

Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer
por: Li, Zi-Yu, et al.
Publicado: (2011)

Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series
por: Hadzitheodorou, Christina, et al.
Publicado: (2017)

The Prognostic Impact of Histology in Esophageal and Esophago-Gastric Junction Adenocarcinoma
por: Fiocca, Roberto, et al.
Publicado: (2021)

Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
por: Trinh, Katherine V., et al.
Publicado: (2020)

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)

ASO Author Reflections: Preventable Mortality Following Esophago-Gastric Cancer Resection
por: Liu, David S., et al.
Publicado: (2023)

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
por: Hu, Qiancheng, et al.
Publicado: (2019)

Anti-angiogenic therapies for advanced esophago-gastric cancer
por: Fontana, Elisa, et al.
Publicado: (2014)

Cervical Esophago-Gastric Tubes for Patients with Malignant Ascites
por: Liang, Diana H., et al.
Publicado: (2016)

Perspectives on the Management of Oligometastatic Disease in Esophago-Gastric Cancer
por: Goetze, Thorsten Oliver, et al.
Publicado: (2022)

Carcinosarcoma of the esophago-gastric junction—a case description
por: Włodarczyk, Janusz, et al.
Publicado: (2022)

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma
por: Gartrell, Robyn D., et al.
Publicado: (2022)

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
por: Matani, Hirsch, et al.
Publicado: (2022)

Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients
por: Ji, Xin, et al.
Publicado: (2017)

Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer
por: Chen, Junbing, et al.
Publicado: (2022)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

PHARYNGO-ILEO-COLO-ANASTOMOSIS WITH MICRO-VASCULAR BLOOD SUPPLY AUGMENTATION FOR ESOPHAGO-GASTRIC REPLACEMENT DUE TO ESOPHAGO-GASTRIC NECROSIS AFTER CAUSTIC INGESTION
por: BRAGHETTO, Italo, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy-Chemoradiation for Borderline-Resectable Pancreatic Adenocarcinoma: A UK Tertiary Surgical Oncology Centre Series
por: Gorbudhun, Rachna, et al.
Publicado: (2022)

Successful Esophago-Enterostomy
Publicado: (1898)

Emergency treatment of esophago-gastric lesion in caustic ingestion patients
por: Conforto, F, et al.
Publicado: (2004)

Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
por: Galindo, José, et al.
Publicado: (2013)

Management of synchronous adenocarcinoma of the esophago-gastric junction and ampulla of Vater: case report of a surgically challenging condition
por: Jayaprakash, Namita, et al.
Publicado: (2009)

The role of anti-EGFR agents in the first-line treatment of advanced esophago-gastric adenocarcinoma: a meta-analysis
por: Kim, Bum Jun, et al.
Publicado: (2017)

The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival
por: Ji, Xin, et al.
Publicado: (2017)

Evaluation of postoperative surveillance strategies for esophago-gastric cancers in the UK and Ireland
por: Chidambaram, Swathikan, et al.
Publicado: (2021)

Management of Esophago-Gastric Junction Carcinoma: A Narrative Multidisciplinary Review
por: Tondolo, Vincenzo, et al.
Publicado: (2023)

Esophago-Pleural Fistula Complicating a Laparoscopic Adjustable Gastric Band
por: Adekunle, Ayooluwatomiwa D., et al.
Publicado: (2022)

The 8th edition of the American Joint Committee on Cancer tumor-node-metastasis staging system for gastric cancer is superior to the 7th edition: results from a Chinese mono-institutional study of 1663 patients
por: Ji, Xin, et al.
Publicado: (2017)

Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis
por: SCHULZE, BJÖRN, et al.
Publicado: (2014)

A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma
por: Crocenzi, Todd, et al.
Publicado: (2016)

The optimal screening interval for gastric cancer using esophago-gastro-duodenoscopy in Japan
por: Kobayashi, Daiki, et al.
Publicado: (2012)

PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study()()
por: Dalah, Entesar, et al.
Publicado: (2018)

Parenteral nutrition during neoadjuvant chemotherapy for patients with non-metastatic gastric or esophago-gastric cancer to reduce postoperative morbidity (PERCOG): study protocol for a randomized controlled trial
por: Mueller, Tara C., et al.
Publicado: (2017)

Endoscopic ultrasound-guided fiducial marker placement for neoadjuvant chemoradiation therapy for resectable pancreatic cancer
por: Ashida, Reiko, et al.
Publicado: (2020)

Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
por: Rizzo, Alessandro
Publicado: (2022)

Pathologic Complete Response After Neoadjuvant Chemoradiation in a Patient with Gastric Neuroendocrine Cancer
por: Laughlin, Brady, et al.
Publicado: (2019)

The Prevention of Venous Thromboembolism After Esophago-Gastric Surgery: A Never-Ending Story
por: Rocco, Raffaele, et al.
Publicado: (2022)

Tumor‐immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas
por: Soeratram, Tanya TD, et al.
Publicado: (2021)

Cohort profile: gastric cancer in the population-based, Finnish National Esophago-Gastric Cancer Cohort (FINEGO) Study
por: Kauppila, Joonas H, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r6l5fkldm60u3qo8qaj8dpjsbo